Immunology/Inflammation


The adaptive immune system consists of B and T lymphocytes which mediate humoral immunity (e.g. antibody response) and cell-mediated immunity, respectively. B cell receptor and T cell receptor signaling is responsible for activation of Src family tyrosine kinases, such as Blk, Fyn, and Lyn in B cells and Fyn and Lck in T cells, resulting phosphorylation of the receptor-associated ITAM motifs. Phosphorylated ITAMs serve as the docking sites for Syk family tyrosine kinases, e.g. Syk in B cells and Zap-70 in T cells. Activated Syk kinases then propagate the signals via phosphorylation of downstream proteins. Furthermore, lymphocyte receptor signaling facilitates B and T cell development, differentiation, proliferation and survival.
-
C6492 IndobufenSummary: A drug that reversibly inhibits platelet aggregation and thromboxane A2 synthesis -
C6495 ActaritSummary: An orally active anti-inflammatory agent for rheumatoid arthritis -
C6501 LentinanSummary: A polysaccharide compound with antitumor, immunomodulatory and antioxidant activities -
C6510 Ciprofloxacin hydrochloride hydrateSummary: A fluoroquinolone topoisomerase inhibitor that induces DNA damage and apoptosis -
C6465 (-)-BorneolSummary: A small-molecule compound that positively modulates the GABA receptor -
B8457 1,3-Dicaffeoylquinic acidSummary: A compound with antioxidant, free-radical-scavenging, and oxidative-damage-protective activities -
B8463 SR-717Summary: A non-nucleoside STING agonist structurally similar to cGAMP with antitumor activity -
B8464 BAY-218Summary: An aryl hydrocarbon receptor antagonist for cancer and immunomodulatory disorders -
B8469 MSA-2Summary: An orally active non-nucleotide STING agonist for antitumor activity -
B8474 NOD-IN-1Summary: A potent inhibitor of nucleotide-binding oligomerization domain (NOD)-like receptors NOD1 and NOD2

